Physician profile
John J Vogel
NPI 1518966167
$2,088.35
in general payments reported to CMS, 2019-2025
15 companies · $10.38 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $168 · 2021: $364 · 2022: $124 · 2023: $585 · 2024: $232 · 2025: $10.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482 · Travel and Lodging: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.23 |
| Travel and Lodging | $345.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $495.01 | 2023-2024 | Iovera |
| Medtronic USA, INC. | $438.50 | 2019-2020 | |
| Boston Scientific Corporation | $174.47 | 2019-2021 | |
| Medtronic, INC. | $155.72 | 2021 | |
| Spr Therapeutics, INC | $145.33 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $143.42 | 2019 | |
| Sumitomo Pharma America, INC. | $135.22 | 2024 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $124.40 | 2022 | |
| Collegium Pharmaceutical, INC. | $76.94 | 2021 | |
| Biodelivery Sciences International, INC. | $63.42 | 2020-2021 | |
| Bioventus LLC | $52.00 | 2023 | Stimrouter Implantable Kit |
| Amgen INC. | $25.76 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $20.18 | 2021 | |
| Pajunk Medical Systems, LP | $20.10 | 2020 | |
| Relievant Medsystems, INC. | $17.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.